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Yelland and Djordjevic complete the
structural description of the neuropilin-1
ectopic region by reporting the crystal
structure of its MAM domain. The domain
adopts a jellyroll fold that is stabilized by a
Ca2+ ion while forming a molecular
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Neuropilins (NRPs) are single-pass transmembrane
receptors involved in several signaling pathways
that regulate key physiological processes such as
vascular morphogenesis and axon guidance. The
MAM domain of NRP, which has previously been
implicated in receptor multimerization, was the only
portion of the ectopic domain of the NRPs for which
the structure, until now, has been elusive. Using site-
directed mutagenesis in the linker region preceding
the MAM domain we generated a protein construct
amenable to crystallization. Here we present the
crystal structure of the MAM domain of human
NRP1 at 2.24 A˚ resolution. The protein exhibits a jelly-
roll topology, with Ca2+ ions bound at the inter-strand
space enhancing the thermostability of the domain.
We show that the MAM domain of NRP1 is mono-
meric in solution and insufficient to drive receptor
dimerization, which leads us to propose a different
role for this domain in the context of NRP membrane
assembly and signaling.
INTRODUCTION
Neuropilins (NRPs) are single-pass transmembrane receptor
proteins with a pivotal role in key physiological processes such
as vasculogenesis, angiogenesis, axonal guidance, and immu-
nomodulation (Parker et al., 2012a; Djordjevic and Driscoll,
2013). In addition to being essential in development, NRPs
have also been implicated in pathologies such as various can-
cers and proliferative retinopathies (Djordjevic and Driscoll,
2013). Therefore, NRPs have attracted significant scientific inter-
est, because the understanding of their structure, regulation, and
molecular basis of signaling mechanisms could be used to
inform cancer therapeutics discovery programs targeting these
receptors.
NRPs regulate cellular responses to signals mediated by a
diverse range of ligands including vascular endothelial growth
factors (VEGFs) (Soker et al., 1997, 1998) and semaphorins
(Kolodkin et al., 1997). NRPs are able to respond to these diverse
ligands owing to the modular organization of their extracellular2008 Structure 24, 2008–2015, November 1, 2016 ª 2016 The Autho
This is an open access article under the CC BY license (http://creativeregion (also referred to as ectodomain). Neuropilin-1 (NRP1)
and neuropilin-2 (NRP2) exhibit distinct expression patterns;
however, they share a common domain organization and 44%
amino acid sequence identity in humans (Kolodkin et al., 1997).
They are composed of five extracellular structural domains,
named a1, at the N terminus, then a2, b1, b2, and c, followed
by a single transmembrane helix and a short cytoplasmic tail.
Several research groups investigated the detailed atomic struc-
ture of the first four extracellular domains, as well as their inter-
action with biological or synthetic ligands (Lee et al., 2002;
Vander Kooi et al., 2007; Appleton et al., 2007; Jarvis et al.,
2010; Parker et al., 2012b; Tsai et al., 2016). It has been shown
that domains a1 and a2 belong to the structural family of CUB
domains and that they are required for interaction with sema-
phorins (Appleton et al., 2007; Nakamura et al., 1998). NRP do-
mains b1 and b2 share structural homology to coagulation factor
V/VIII domains andwhile both are required formaintaining recep-
tor integrity, series of functional and structural studies have
demonstrated that VEGFs interact with the NRPs by binding of
the C-terminal ends of VEGFs to the specific site on the b1
domain (Vander Kooi et al., 2007; Tsai et al., 2016).
The membrane proximal c domain of NRPs is also called the
MAM domain (referred to as such in the rest of the text) based
on its sequence homology to the equivalent domains in meprin,
A5, and mu-phosphatase (RPTPmu) (Takagi et al., 1991; Beck-
mann and Bork, 1993). While the structures of the other extra-
cellular domains of NRPs have been investigated extensively,
in isolation or in the context of the longer protein constructs,
the structure of the MAM domain remained elusive. Currently,
there is no evidence that the MAM domain participates directly
in an interaction with any of the known ligands for NRPs.
Instead, it was proposed that this domain supports dimerization
and multimerization of NRP molecules and thus contributes
to the formation of signaling receptor complexes (Nakamura
et al., 1998). Namely, as the short intracellular domain of
NRPs does not display any catalytic activity, NRPs exert their
action by combining with other transmembrane receptors,
most notably VEGF receptors thereby responding to VEGFs,
and plexins, responding to semaphorins. How exactly MAM
domains contribute to multimerization and receptor complex
formation has not been fully explained and the evidence sup-
porting this view is somewhat weak, relying primarily on the
immunoprecipitation experiments carried out on various domain
deletion mutants of NRPs (Giger et al., 1998; Nakamura et al.,
1998).rs. Published by Elsevier Ltd.
commons.org/licenses/by/4.0/).
Figure 1. Thermal Stability Assay for Buffer Optimization of the
ngMAM Domain
The melting temperature of the ngMAM domain (blue curve) increases by
10C on addition of 10 mM CaCl2 (red curve).
Table 1. Data Collection and Refinement Statistics
Data Statistics
Space group P 21 21 21
Cell dimensions
a, b, c (A˚) 46.17, 59.56, 136.65
a, b, g () 90.00, 90.00, 90.00
Resolution (A˚) 46.17–2.24 (2.31–2.24)
Rmerge 0.11 (0.41)
Completeness (%) 98.3 (96.5)
Multiplicity 6.2 (6.0)
CC1/2 0.997 (0.909)
I/s (I) 16 (5.4)
Refinement
Total no. of observations 114,824





Mean B factors (A˚2) 25.33
Ramachandran plot (%)
Residues in favored region 95.13
Residues in allowed region 3.72
Residues in disallowed region 1.15
Numbers in parentheses refer to the highest-resolution data shell. RMSD,
root-mean-square deviation.We were able to generate a protein variant amenable to crys-
tallization and we now report the first crystal structure of the
MAM domain from NRPs, thus completing the structural charac-
terization of the ectodomain of this receptor family. The crystal
structure confirms that the domain shares an overall topology
with the homologous domain of RPTPmu; however, we see no
evidence that the NRP1MAM domain forms biologically relevant
dimers. This observation is also corroborated by the solution
studies of the protein. We propose that while the MAM domain
on its own is not sufficient to support multimerization of NRP
molecules it might contribute to the assembly and regulation
of the signaling complexes either by positioning the other
extracellular domains of NRPs away from the membrane, and
in an orientation suitable for protein/protein interaction, or via
glycan-mediated interaction of the MAM domain with other pro-
teins of the extracellular matrix.
RESULTS AND DISCUSSION
Buffer and Construct Optimization for Crystallization
Suggests Calcium Binding
We have previously determined that the specific serine and thre-
onine residues upstream of the predicted MAM domain of NRP1
are glycosylated (Windwarder et al., 2016), producing a non-
homogeneous protein sample which was not suitable for crystal-
lization. To overcome this issue all residues that are potential
substrates for glycosylation were changed to aspartates to
exclude heterogeneity while maintaining negatively charged fea-
tures of the protein region, thus partially mimicking the effect of
glycosylation; this protein variant was named a non-glycosylated
MAM (ngMAM) domain. Even though the glycosylation sites
were predicted to be located in an unstructured region preced-
ing the residues contributing to the MAM domain fold, prior
efforts to remove the glycosylated residues through the gener-
ation of truncated constructs resulted in significantly lower
expression levels, suggesting that the N-terminal disordered re-gion is necessary for maintaining protein solubility. The ngMAM
protein exhibited reduced solubility (25 mg/mL) compared with
the wild-type (WT) protein (>150 mg/mL) and this property has
proved beneficial for crystallization trials. In all other respects,
the ngMAM protein behaved as a WT protein with similar levels
of expression and elution profiles on a size-exclusion chroma-
tography column.
To further stabilize the protein, buffer optimization was carried
out using a thermal melt assay which identified that divalent
cations, particularly Ca2+ and Mg2+, increased protein thermal
stability by 10C (Figure 1). Consequently, 10 mM CaCl2 was
added to the protein solution prior to screening of crystallization
conditions.
Crystal Structure of the MAM Domain of NRP1
The NRP1 ngMAM domain protein crystallized with two mole-
cules in the asymmetric unit (X-ray crystallography statistics
are presented in Table 1). The electron density maps allowed
model building for residues 639–813 in chain A and 641–815 in
chain B while the N-terminal region (residues 628–639), which
contains four of themutated residues that would be glycosylated
in the WT protein, as well as the (His)6 C-terminal tag, was disor-
dered. This is not surprising given the large number of charged
residues in these regions preventing stable secondary structure
formation. As the N-terminal region containingmutated glycosyl-
ation sites is unstructured and does not contribute to the overall
MAM domain protein fold for the rest of the description and dis-
cussion we will refer to the MAM domain structure even thoughStructure 24, 2008–2015, November 1, 2016 2009
Figure 2. Crystal Structure of the MAM
Domain of NRP1
(A) The crystal structure of the MAM domain in
cartoon representation colored as a spectrum from
blue to red from the N to the C terminus. The
structure contains 10 b strands and three short
a-helical turns. The two calcium atoms are shown
as black spheres.
(B) The dimer within the asymmetric unit shown in
cartoon representation with one chain in yellow
and the second in green.
(C) The crystal structure of the MAM domain re-
vealed two calcium-binding sites in close prox-
imity. The calcium-binding sites are shown in
stereo view. First Ca2+ (black sphere) is coordi-
nated by E651, D685, N691, and D796 as well as a
single water molecule (W1). The second Ca2+ is
coordinated by two water molecules (W2 and W3),
D685, and a bicine molecule present within the
crystallization condition. The coordinate bonds are
shown by black dashed lines. The water molecules
are shown as blue spheres while amino acid side
chains (yellow) and a bicine molecule (pink) are
shown in stick representation. Electron density
(2Fo Fc) is contoured at 1.6 s and represented as
a wire mesh.the protein used for crystallization was that of a ngMAM variant.
The crystal structure of the MAM domain of NRP1 comprises a
variable N-terminal region that contains a short a helix con-
nected through an extensive linker to a single b strand (bA),
and an adjacent eight-stranded b barrel organized in a jellyroll
topology, with the strands named B-I, followed by the short
a-helical turn at the C terminus (Figure 2A). The b strands within
the domain undergo a significant twist relative to each other such
that the bA is almost perpendicular to the bC. The N-terminal
a-helical turn may not be a stable structural feature, as it is pre-
sent in only one of the twomonomers within the asymmetric unit.
In addition to the polypeptide chain, we were also able to identify
two Ca2+ ions and a molecule of bicine associated with each of
the NRP1 molecules within the asymmetric unit.
The molecular interface observed in the crystal structure (Fig-
ure 2B) is unlikely to be biologically significant as determined
using the PISA server (http://www.ebi.ac.uk/pdbe/pisa/), which
calculated the largest interface between MAM monomers to
cover 564 A˚2 and with a complexation significance score (based
on a calculated DG upon dimer formation) of 0.0. Therefore the
observed dimer in the asymmetric unit is possibly a crystallo-
graphic artifact of no physiological relevance. In contrast to the
meprin MAM domain (Arolas et al., 2012), which contains five
cysteine residues in theMAMdomain of NRP1, no intermolecular
disulfide bond can be formed as the four cysteine side chains
present form intramolecular disulfide bonds, thus eliminating
cysteine-dependent oligomerization as a mechanism of NRP12010 Structure 24, 2008–2015, November 1, 2016self-association. However, it has recently
been postulated that the integrity of
the intramolecular disulfide bonds might
regulate NRP oligomerization (Barton
et al., 2015). The crystal structure pre-
sented here indicates that disruption ofthe disulfide bonds would affect the stability of the MAM domain
and consequently the full ectopic domain.
Calcium-Binding Site
The initial difference electron density maps contained distinct
high-intensity peaks near residues E651, D685, and D796 and
these were interpreted as Ca2+ ions (Figure 2C). Even though
both Mg2+ and Ca2+ ions were present under the crystallization
conditions, the concentration of CaCl2 was higher, with an
additional 10 mM CaCl2 added to the protein buffer used for
crystallization. Further confirmation that the ion within the struc-
ture was Ca2+ came from the analysis of the coordination geom-
etry. A calcium ion is coordinated by a single oxygen from the
side-chain carboxyl groups from residues E651 and D685, both
oxygen atoms of the side-chain carboxyl group of D796, the
backbone carbonyl oxygen atoms from residues E651 and
N691 as well as one water molecule (Figure 2C), to give a total
of seven coordination interactions with octahedral geometry (as
determined using the CMM server, http://www.csgid.org/csgid/
metal_sites#home-anchor). This geometry is consistent with a
calcium-binding site based on the surveys of deposited crystal
structures (Glusker et al., 1996; Harding, 2004) and Fourier trans-
form infrared spectroscopy studies (Nara et al., 2013). In addition,
refined distances for metal-ligand oxygen in the structure of
NRP1 MAM are around 2.4 A˚ which is what would be expected
for aCa2+/ligand interaction (Zheng et al., 2008), although it could
not be excluded that under physiological conditions Mg2+ could
also bind at the same site. The second Ca2+, located within 5.6 A˚
of the first, is coordinated by four atoms from a bicine molecule
present in the crystallization buffer, two water molecules, and
an oxygen atom from the b-carboxylate of the D685 side chain,
arranged around a Ca2+ ion in pentagonal bipyramidal geometry.
D685, in fact, bridges the two calcium ionswith the b-carboxylate
engaged with each of the ions by one of the two oxygen atoms.
Given that bicine is a constituent of the crystallization solution,
the second Ca2+ binding site may not be of a physiological signif-
icance. The two Ca2+ binding sites are present in both MAM
domain molecules within the asymmetric unit and stabilize the
domain by bridging the residues from the N-terminal variable re-
gion to the first and the last strand of the jellyroll (Figure 2).
The residues contributing to the coordination of the first cal-
cium ion are conserved in the MAM domains from meprin and
RPTPmu even though, in both crystal structures, they have
been modeled as coordinating to sodium ions. In contrast, it is
unlikely that theMAMdomain of NRP2would bind calcium; while
the residues corresponding to N691 and D796 are conserved,
the other two residues from the binding site, E651 and D685,
correspond to an asparagine and a threonine, respectively (Fig-
ure 3A). Previously, it was reported that the NRP1 a1a2 domains
also contain a calcium-binding site (Appleton et al., 2007) and
it has recently been shown that the b1 domain of NRP2 has a
specific Zn2+ ion binding site (Tsai et al., 2016). Therefore, the
signaling potential of NRPs might be additionally regulated by
homeostasis of divalent ions.
Comparison with the MAM Domains from RPTPmu and
Meprin
Overlaying the MAM domain structure from RPTPmu (PDB:
2C9A, residues 1–187, 25% sequence identity to NRP1) (Ari-
cescu et al., 2006) and meprin (PDB: 4GWM, residues 257–
428, 29% sequence identity to NRP1) (Arolas et al., 2012) to
that of NRP1 gives an RMSD for Ca atoms of 1.6 A˚ and 1.7 A˚,
respectively (Figure 3B). The b strands overlap very well while
the flexible loops are the main source of variation between the
three structures. It appears that the central b barrel of the
MAM domains provides a scaffold that displays the loop regions
which are crucial determinants of the function of the individual
domains in the context of the various full-length proteins (Ari-
cescu et al., 2006).
This conclusion is reinforced by the analysis of the MAM
domain structures which revealed a highly hydrophobic core
spanning the entire length of the fold. In NRP1 the aromatic res-
idues F652, W673, F692, F724, Y726, W753, W763, and F781
are arranged in a coordinated manner to optimize p-stacking
interactions between the aromatic side chains (Figure 3C). In
the core of RPTPmu these residues are conserved and superim-
pose very well with the NRP1 residues. In meprins, most of the
corresponding residues are also conserved with the exception
of the NRP1 W753 which, in meprins, is located at the solvent-
exposed edge of the domain and corresponds to Q/E (for
meprinA/meprinB) (Figure 3A).
Further analysis of sequence conservation between the three
proteins reveals that, apart from the residues contributing to
the hydrophobic core there is only one sequence stretch of sig-
nificant homology, spanning NRP1 residues G791 to I800. Inter-
estingly, this area includes the key residue (D796) contributing tothe binding of the Ca2+ ion. Despite the conserved central b
structure, connecting loops are very different in both amino
acid composition and the length. Even when the surface loops
of equivalent lengths are considered, such as the loop connect-
ing bE to bF, the 3D positions of the equivalent Ca residues are
up to 7 A˚ apart, thus creating a distinct molecular surface for
each of the proteins.
MAM Domains Utilize Different Molecular Surfaces to
Engage in Protein/Protein Interactions
Differences in the structures of the loop regions give rise to the
significantly different molecular surfaces of the various MAM do-
mains (Figure 4A). Comparison of the electrostatic surface po-
tentials for the structures of NRP1, RPTPmu, and meprin MAM
domains demonstrates that while all structures display a mixture
of polar and hydrophobic patches there are clear differences in
the molecular shapes and the distribution of charges within the
three electrostatic surface potentials, suggesting that the three
homologous domains would be engaged in a distinct set of intra-
or intermolecular protein/protein interactions.
MAM domains have been widely implicated in protein oligo-
merization and receptors assembly; however, the mechanisms
they employ to facilitate protein/protein interactions remain un-
der-determined. The structures of the RPTPmu MAM domain
in a context of a MAM-Ig domain (PDB: 2C9A) (Aricescu et al.,
2006), and as a part of the full-length ectodomain (PDB: 2V5Y)
(Aricescu et al., 2007), indicated that the N-terminal MAM
domain is involved in receptor dimerization but not through
homo-domain interactions; instead, the domain binds to an FNIII
domain of a neighboring molecule in a pH-dependent manner
(Aricescu et al., 2006). Furthermore, within the antiparallel dimer
of the RPTPmu ectodomain, both the MAM and Ig domain
contribute to the molecular surface interacting with the FNIII
domain (Aricescu et al., 2007). In NRPs, the MAM domain is
located proximal to the membrane and thus, despite the similar-
ity to the fold of the RPTPmu MAM domain it would be unlikely
that similar set of domain/domain interactions would also be
observed within the context of a full-length NRP1.
Even though it had been postulated that the MAM domain of
NRP1 would be engaged in homo- and hetero-dimerization,
the evidence for this hypothesis is weak, relying mostly on
cell-based experiments with NRP1 variants where individual do-
mains have been deleted (Nakamura et al., 1998). Using size-
exclusion chromatography, we have previously estimated that
an40 mMWT glycosylated MAM domain is monomeric in solu-
tion (Windwarder et al., 2016), while the structure presented here
contains two molecules in the asymmetric unit (Figure 2B). To
further assess the potential of the NRP1 MAM domain to form
homo-dimers or homo-oligomers we used isothermal titration
calorimetry for which a highly concentrated purified MAM
domain (900 mM) was titrated into a buffer solution (Figure 4B).
If the MAM domain was present as a dimer at the initial concen-
trations, injection of the concentrated MAM domain to the buffer
chamber would result in a 200-fold dilution of the initial concen-
tration down to <5 mM, and if the protein existed primarily as a
dimer at the initial concentration, the protein molecules would
dissociate at the lower concentration with an accompanying
enthalpy change. However, no measurable heats of dissociation
were detected by the instrument. This result suggests that if theStructure 24, 2008–2015, November 1, 2016 2011
Figure 3. Conservation of Structure of MAM Domains in Relation to Amino Acid Sequence
(A) Sequence alignment of the MAM domain from NRPs, RPTPmu, and meprins show the aromatic residues that are highly conserved (red-shaded) between the
different proteins. Secondary structure elements present in the NRP1 domain are depicted above the corresponding sequence. Conserved cysteines involved in
intramolecular disulfide bonds are highlighted in green shading. Sequence numbering refers to NRP1MAM domain only. In addition, a solvent-exposed cysteine
residue that is present in the meprin protein and involved in disulfide-linked dimerization is highlighted in blue.
(B) Overlay of theMAMdomains fromRPTPmu (blue, residues 1–187; PDB: 2C9A) andmeprin (pink, residues 257–428; PDB: 4GWN) to theMAMdomain of NRP1
(yellow, PDB: 5L73) in cartoon representation. The secondary structure elements are conserved but there is a large amount of variation within the loop regions.
(C) The MAM domain has a conserved hydrophobic core. The MAM domains of NRP1 (yellow), meprin (pink), and RPTPmu (blue) contain a hydrophobic core
consisting of aromatic residues F652, W673, F692, F724, Y726, W753, W763, and F781 (NRP1 numbering), shown in stick representation.MAMdomain was to homo-oligomerize then the self-association
affinity would be weak and with a corresponding dissociation
constant higher than 900 mM. Our experiments, in agreement
with the previously reported light-scattering data (Appleton
et al., 2007), do not demonstrate self-association of the MAM
domain.2012 Structure 24, 2008–2015, November 1, 2016We, therefore, propose a different role for the MAM domain
in the context of NRP signaling, where it would act as an
insulator, shielding the rest of the ectodomain from the mem-
brane environment and positioning other domains (a1a2b1b2)
for their interaction with partner co-receptors. Alternatively,
it may serve to modulate signaling and multimerization
Figure 4. Different MAM Domains Might Be Engaged in a Distinct Set of Protein/Protein Interactions
(A) Molecular surface electrostatic potential of the MAM domains from NRP1, NRP2, RPTPmu, and meprin. The structures are shown in the same orientation.
NRP2 MAM was modeled based on the structure of NRP1 reported here. For the surface of NRP2, the green arrow points to the region, recently described as
being engaged in interaction with polysialyltransferase (Bhide et al., 2016). See also Figure S1.
(B) NRP1 MAM exhibits a monomeric structure in solution, as suggested by isothermal titration calorimetry experiments. Titration of NRP1 MAM domain into a
buffer solution at 15C (left) and 20C (right). Top panels show raw data while the bottompanels contain a binding isotherm obtained by integrating the peaks from
the top panel.events through interactions with other binding partners, such
as galectins (GALs). It has been shown that GAL-1 (Camby
et al., 2006) affects both angiogenesis and neuronal develop-
ment (Quinta et al., 2014) and that it binds to NRP1. Although
the molecular basis of this interaction is unknown, it is possible
that GAL-1 associates with the glycans upstream of the NRP1
MAM, thereby bridging the NRP ectodomains. In a recentreport (Bhide et al., 2016), two glutamate residues in the
NRP2 MAM domain were identified as the recognition site for
the polysialyltransferase (an enzyme that specifically modifies
NRP2 but not NRP1). In our molecular model of the NRP2
MAM domain these residues are located on the unique protru-
sion of the molecular surface (Figure 4A), further supporting our
suggestion that, in NRPs, the MAM domains interact with theStructure 24, 2008–2015, November 1, 2016 2013
specific regulatory proteins by utilizing distinct molecular
surfaces.
EXPERIMENTAL PROCEDURES
Expression and Purification of the MAM Domains
A gene construct coding for amino acid residues 628–813 of human NRP1was
cloned into the vector pOPINTGneo (Berrow et al., 2009). The DNAwas cloned
in frame with the secretion leader sequence to ensure that the resulting protein
was exported through the secretory pathway. The corresponding protein
product referred to as a ‘‘MAMdomain,’’ was used for analytical size-exclusion
chromatography and isothermal titration calorimetry experiments.
For the production of a ngMAM domain, the gene construct, cloned into the
vector pSecTag2 A (Thermo Fisher Scientific), was purchased from Life Tech-
nologies. In this expression construct, the codons corresponding to residues
T629, T633, S637, T638, S641, and T645 were replaced with the codons for
aspartate. The mutated residues removed the O-linked glycosylation sites to
produce a homogeneous protein sample suitable for crystallization. The pro-
tein was cloned in frame with the Ig K-chain leader so that the MAM domain
was exported through the native secretory pathway. A non-cleavable (His)6-
purification tag was fused to the C terminus.
All large-scale expression protocols were carried out as follows: transfection
of the 1 L cultures of FreeStyle HEK293-F cells (Thermo Fisher Scientific) at
a density of 1.0–1.4 3 106 cells/mL was performed using 1.25 mg of DNA
and 1.87 mg of polyethylenimine (Sigma) in 40 mL of OptiPro (Life Technolo-
gies) supplemented with 4 mM L-glutamine (Sigma). Cells were incubated
at 37C, shook at 125 rpm for 4 days before being harvested by centrifugation
at 1,000 3 g for 10 min. The supernatant was filtered and loaded onto a 1 mL
Ni2+-ion affinity HisTrap column (GEHealthcare). The columnwaswashedwith
10 column volumes of a buffer containing 20 mM Tris (pH 8.0) and 100 mM
NaCl before the elution step with 5 column volumes of the buffer containing
an additional 300mM imidazole. The protein was further purified by size-exclu-
sion chromatography on a Superdex S200 10/300 GL column (GE Healthcare).
All protein concentrations were estimated based on absorbance at 280 nm.
Crystallographic Studies
Crystallization
Purified ngMAM protein was concentrated to 15 mg/mL using centrifugal
concentrators (10 kDa molecular-mass cutoff, Vivaspin, Vivascience, Thermo
Fisher Scientific) before adding CaCl2 to a final concentration of 10 mM. Crys-
tallization screening was performed using a mosquito (TTP Labtech) and a
sparse matrix kit from Hampton Research (Index), Molecular Dimensions
(Morpheus, PACT and JCSG), and QIAGEN (PEGS II). Rod-shaped crystals
(100 mM in length) grew at 16C, in a solution containing 0.06 M MgCl2,
0.06 M CaCl2, 0.1 M Tris (base), 0.1 M bicine (pH 8.0), 12.5% MPD, 12.5%
PEG 1000 and 12.5% (w/v) PEG 3350. The crystals were flash frozen directly
in liquid nitrogen prior to data collection.
Data Collection and Structure Determination
Diffraction data were collected at Diamond Light Source, beamline I04. Data
were processed using Xia2 (Winter, 2010) and reindexedwith Pointless (Evans,
2011) before phasing with the molecular replacement method using Phaser
(McCoy et al., 2007). For a search model, the structure of the MAM domain
from RPTPmu (PDB: 2C9A, residues 21–177) was used (omitting all water mol-
ecules and glycans). We were unable to obtain the solution until the following
loop and flexible regions were omitted: residues 21–36, 51–67, 89–95, 106–
108, 121–125, 147–154; the side chains of the remaining residues were cut
to Cb using Chainsaw (Stein, 2008). The structure was built using iterative
rounds of model building in Coot (Emsley et al., 2010) and a restrained refine-
ment routine in Refmac5 (Murshudov et al., 1997). All figures of crystal struc-
tures and molecular surface calculations were prepared using PyMol (http://
www.pymol.org).
Isothermal Titration Calorimetry
MAM domain dissociation experiments were performed using a MicroCal
iTC200 (Malvern) instrument. The sample cell was filled with buffer (20 mM
Tris [pH 8.0], 100 mM NaCl) and the syringe contained 900 mM of the MAM
domain in an identical buffer solution. The MAM domain solution was then2014 Structure 24, 2008–2015, November 1, 2016titrated into the buffer with one 0.4 mL injection that was followed by 19 injec-
tions of 2 mL. The experiments were performed at 15C and 20Cwith a stirring
rate of 1,000 rpm.
Thermostability Assay
Each well in a 96-well plate contained SYPRO orange (Sigma-Aldrich) at a final
13 concentration, 5 mM of the ngMAM domain, a 2 mL solution from a single
condition from the Hampton Research crystallographic additive screen and
a buffer (10 mM Tris [pH 8.0], 100 mM NaCl) up to a total volume of 20 mL.
The plate was placed in a LightCycler 480 II (Roche) and the samples were
heated from 10C to 90C at a rate of 5C per min. Fluorescence was moni-
tored at 570 nm.
Molecular Modeling of the NRP2 MAM Domain
Generation of the NRP2 MAM domain model structure was performed using
MODELLER v9.16 (Webb and Sali, 2014) and using the NRP1 MAM domain
as a template (35% sequence identity). Sequence alignments and model gen-
eration was performed following the online manual methodology (https://
salilab.org/modeller/tutorial/).
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